Autres langues Biocept, Inc.

Actions

BIOCQ

US09072V6002

Temps Différé OTC Markets Autres places de cotation 21:02:01 23/04/2024			Varia. 5j.	Varia. 1 janv.
0,0001 ^USD	0,00%		0,00%	-99,76%

2023	Biocept, Inc. Déposée en faillite	CI
2023	Biocept, Inc. annonce le recrutement complet de 40 sujets atteints de cancer du sein ou de cancer du poumon non à petites cellules	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Motion for Asset Sale Approved for Biocept, Inc.	26/04
Motion for Asset Sale Approved for Biocept, Inc.	02/04
Biocept, Inc.(OTCPK:BIOC.Q) dropped from NASDAQ Composite Index	24/10/23
Biocept, Inc.(NasdaqCM:BIOC) dropped from S&P TMI Index	19/10/23
Biocept : Bankruptcy - Form 8-K	16/10/23
Biocept, Inc. Filed for Bankruptcy	13/10/23
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept's CNSide Assay to Evaluate Patients with Leptomeningeal Metastases	22/09/23
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases	21/09/23
Biocept, Inc. Announces the Full Enrollment of 40 Subjects with Breast or Non-Small Cell Lung Cancer	21/09/23
Biocept Signs CNSide Licensing Agreement with plus Therapeutics	11/09/23
Sector Update: Health Care Stocks Slipping Late Friday8 Afternoon	08/09/23
Sector Update: Health Care Stocks Slipping Friday Afternoon	08/09/23
Sector Update: Health Care	08/09/23
Biocept Signs Non-Exclusive Licensing Agreement With Plus Therapeutics on CNSide Tumor Cell Platform	08/09/23
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike	08/09/23
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics	08/09/23
Top Premarket Gainers	08/09/23
Plus Therapeutics, Inc. Enters into License Agreement with Biocept for Cerebrospinal Fluid Tumor Cell Enumeration Assay	08/09/23
Biocept to Participate in the H.C. Wainwright Global Investment Conference	05/09/23
Biocept to Hold Business Update Conference Call on August 30, 2023	28/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Biocept, Inc.

Actions

BIOCQ

US09072V6002

Autres langues

Filtres